United States Biotechnology & Medical Research

Bioverativ Inc (BIVV)

Track

Track

Ticker: BIVV Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Posner Brian S
Transaction date
Purchase
Price
476.13
Quantity 13,277 +29.9%
Value US$3,162,359
PAGLIA LOUIS J
Transaction date
Purchase
Price
396.70
Quantity 21,216 +25.7%
Value US$1,800,859
Duvall Diantha Chief Accounting Officer
Transaction date
Planned sale
Price
316.09
Quantity 72,114 -13.2%
Value US$53,375
DENNER ALEXANDER J
Transaction date
Purchase
Price
55.93
Quantity 90,000 +8.4%
Value US$5,033,475
PAGLIA LOUIS J Non-Executive Director
Transaction date
Purchase
Price
57.76
Quantity 2,000 +189.4%
Value US$115,520
DENNER ALEXANDER J Non-Executive Director
Transaction date
Purchase
Price
57.21
Quantity 450,000 +72.0%
Value US$25,745,130
DENNER ALEXANDER J Non-Executive Director
Transaction date
Purchase
Price
54.98
Quantity 130,000 +26.3%
Value US$7,147,907
DENNER ALEXANDER J Non-Executive Director
Transaction date
Purchase
Price
54.16
Quantity 340,000 +219.4%
Value US$18,414,400
Posner Brian S Non-Executive Director
Transaction date
Purchase
Price
53.79
Quantity 700 +14.0%
Value US$37,656
Posner Brian S Non-Executive Director
Transaction date
Purchase
Price
53.90
Quantity 1,300 +35.2%
Value US$70,068
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-08-10 2017-08-09 B Purchase Posner Brian S
13,277 +29.9%
476.13
US$3,162,359 		13,277 +29.9% 476.13 US$3,162,359
2017-08-08 2017-08-07 B Purchase PAGLIA LOUIS J
21,216 +25.7%
396.70
US$1,800,859 		21,216 +25.7% 396.70 US$1,800,859
2017-06-29 2017-06-28 PlS Planned sale Duvall Diantha

Chief Accounting Officer
72,114 -13.2%
316.09
US$53,375 		72,114 -13.2% 316.09 US$53,375
2017-06-01 2017-05-30 B Purchase DENNER ALEXANDER J
90,000 +8.4%
55.93
US$5,033,475 		90,000 +8.4% 55.93 US$5,033,475
2017-05-26 2017-05-26 B Purchase PAGLIA LOUIS J Non-Executive Director
2,000 +189.4%
57.76
US$115,520 		2,000 +189.4% 57.76 US$115,520
2017-05-26 2017-05-26 B Purchase DENNER ALEXANDER J Non-Executive Director
450,000 +72.0%
57.21
US$25,745,130 		450,000 +72.0% 57.21 US$25,745,130
2017-05-26 2017-05-25 B Purchase DENNER ALEXANDER J Non-Executive Director
130,000 +26.3%
54.98
US$7,147,907 		130,000 +26.3% 54.98 US$7,147,907
2017-05-26 2017-05-24 B Purchase DENNER ALEXANDER J Non-Executive Director
340,000 +219.4%
54.16
US$18,414,400 		340,000 +219.4% 54.16 US$18,414,400
2017-05-24 2017-05-24 B Purchase Posner Brian S Non-Executive Director
700 +14.0%
53.79
US$37,656 		700 +14.0% 53.79 US$37,656
2017-05-24 2017-05-24 B Purchase Posner Brian S Non-Executive Director
1,300 +35.2%
53.90
US$70,068 		1,300 +35.2% 53.90 US$70,068
Explore more

More insider trading research around Bioverativ Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America